March 28, 2013 / 12:57 PM / 4 years ago

BRIEF-Oncolytics Biotech U.S.-listed shares up in premarket after lung cancer drug meets main goal of mid-stage study

1 Min Read

NEW YORK, March 28 (Reuters) - Oncolytics Biotech Inc : * Oncolytics Biotech U.S.-listed shares up 9 percent to $3.26 in premarket after lung cancer drug meets main goal of mid-stage study

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below